Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biommune Technologie (TSV:PAS)

N/A UNCHANGED
Last Price Updated: 9:30 AM EST, Dec 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Biommune Technologie

News headline image
Rob Gietl Joins Pascal Biosciences as New Chief Executive Officer
VANCOUVER, BC / ACCESSWIRE / September 7, 2021 / Pascal Biosciences Inc. ("Pascal") (TSXV:PAS) (OTC:PSCBF) (FSE: 6PB-FF), announced today the appointment of Rob Gietl as Chief Executive Officer and... 
From Pascal Biosciences Inc.
Via AccessWire
Topics Cannabis Intellectual Property
News headline image
Hardy Forzley Joins Pascal Biosciences as Chief Financial Officer
VANCOUVER, BC / ACCESSWIRE / June 16, 2021 / Pascal Biosciences Inc. ("Pascal") (TSXV:PAS) (OTC PINK:PSCBF) (FSE:6PB), announced today the appointment of Hardy Forzley as Chief Financial Officer. Mr.... 
From Pascal Biosciences Inc.
Via AccessWire
Topics Intellectual Property
News headline image
Pascal Biosciences Awarded NIH Grant For Leukemia Program
VANCOUVER, BC / ACCESSWIRE / June 8, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:PSCBF), has been awarded a grant of US$343,750 from the National Cancer Institute of... 
From Pascal Biosciences Inc.
Via AccessWire
Topics Intellectual Property
News headline image
Pascal Biosciences Announces New OTC Markets Trading Symbol PSCBF
VANCOUVER, BC / ACCESSWIRE / June 1, 2021 / Pascal Biosciences Inc. ("Pascal" or the "Company") (TSXV:PAS)(OTC PINK:PSCBF, previously BIMUF), has today received a new Over The Counter (OTC) trading... 
From Pascal Biosciences Inc.
Via AccessWire
Topics Intellectual Property Regulatory Compliance
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.